HUP9900679A3 - Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation, process for producing them and pharmaceutical compositions containing them - Google Patents
Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation, process for producing them and pharmaceutical compositions containing themInfo
- Publication number
- HUP9900679A3 HUP9900679A3 HU9900679A HUP9900679A HUP9900679A3 HU P9900679 A3 HUP9900679 A3 HU P9900679A3 HU 9900679 A HU9900679 A HU 9900679A HU P9900679 A HUP9900679 A HU P9900679A HU P9900679 A3 HUP9900679 A3 HU P9900679A3
- Authority
- HU
- Hungary
- Prior art keywords
- inhibitors
- producing
- pharmaceutical compositions
- cell proliferation
- compositions containing
- Prior art date
Links
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 title 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 title 1
- 230000004663 cell proliferation Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/468,271 US6444694B1 (en) | 1995-06-06 | 1995-06-06 | Styryl benzimidazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9900679A2 HUP9900679A2 (hu) | 1999-09-28 |
| HUP9900679A3 true HUP9900679A3 (en) | 2001-07-30 |
Family
ID=23859136
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900679A HUP9900679A3 (en) | 1995-06-06 | 1996-06-03 | Benzimidazole derivatives as inhibitors of smooth muscle cell proliferation, process for producing them and pharmaceutical compositions containing them |
| HU9900914A HUP9900914A2 (hu) | 1995-06-06 | 1996-06-03 | Simaizom sejtburjánzást gátló sztiril-benzimidazol-származékok |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900914A HUP9900914A2 (hu) | 1995-06-06 | 1996-06-03 | Simaizom sejtburjánzást gátló sztiril-benzimidazol-származékok |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US6444694B1 (hu) |
| EP (1) | EP0830345B1 (hu) |
| JP (1) | JPH11506753A (hu) |
| KR (1) | KR19990022266A (hu) |
| CN (1) | CN1192206A (hu) |
| AR (1) | AR002749A1 (hu) |
| AT (1) | ATE205196T1 (hu) |
| AU (1) | AU711965B2 (hu) |
| BR (1) | BR9609153A (hu) |
| CA (1) | CA2223585A1 (hu) |
| DE (1) | DE69615023T2 (hu) |
| DK (1) | DK0830345T3 (hu) |
| ES (1) | ES2162063T3 (hu) |
| HU (2) | HUP9900679A3 (hu) |
| IL (1) | IL118385A0 (hu) |
| NZ (1) | NZ309499A (hu) |
| PT (1) | PT830345E (hu) |
| WO (1) | WO1996039391A1 (hu) |
| ZA (1) | ZA964693B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
| EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| EA200901463A1 (ru) | 2004-02-20 | 2010-08-30 | Бёрингер Ингельхайм Интернациональ Гмбх | Ингибиторы вирусной полимеразы |
| WO2007019674A1 (en) | 2005-08-12 | 2007-02-22 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| KR101565271B1 (ko) | 2006-07-05 | 2015-11-02 | 피브로테크 세라퓨틱 피티와이 엘티디 | 치료 화합물 |
| EP2491030B1 (en) * | 2009-10-22 | 2015-07-15 | Fibrotech Therapeutics PTY LTD | Fused ring analogues of anti-fibrotic agents |
| WO2018144620A1 (en) | 2017-02-03 | 2018-08-09 | Shire Human Genetic Therapies, Inc. | Anti-fibrotic compounds |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3575956A (en) * | 1967-07-24 | 1971-04-20 | Sterling Drug Inc | 2-substituted-benz-x-azol-6-ylazo-aminonaphthalene compounds |
| DE1670908A1 (de) * | 1967-08-16 | 1971-04-29 | Hoechst Ag | Neue Benzimidazolverbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung als optische Aufhellungsmittel |
| FR2104717A1 (en) * | 1970-09-28 | 1972-04-21 | Dynachim Sarl | Organophosphorus pesticides stabilised with benzimidazole derivs - - for controlling insects and internal parasites of animals |
| DE3505609A1 (de) | 1985-02-19 | 1986-08-21 | Merck Patent Gmbh, 6100 Darmstadt | Benzimidazolyl-pyridazinone |
| CA2080582A1 (en) | 1990-04-16 | 1991-10-17 | Alfred P. Spada | Heterocyclicethenediyl compounds which inhibit egf receptor tyrosine kinase |
| US5196446A (en) | 1990-04-16 | 1993-03-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Certain indole compounds which inhibit EGF receptor tyrosine kinase |
| DE4212748A1 (de) | 1992-04-16 | 1993-10-21 | Thomae Gmbh Dr K | Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| US5387600A (en) | 1992-07-30 | 1995-02-07 | Fuji Photo Film Co., Ltd. | Treating arteriosclerosis using benzimidazole compositions |
-
1995
- 1995-06-06 US US08/468,271 patent/US6444694B1/en not_active Expired - Fee Related
-
1996
- 1996-05-22 IL IL11838596A patent/IL118385A0/xx unknown
- 1996-05-30 AR ARP960102799A patent/AR002749A1/es unknown
- 1996-06-03 KR KR1019970708745A patent/KR19990022266A/ko not_active Application Discontinuation
- 1996-06-03 DE DE69615023T patent/DE69615023T2/de not_active Expired - Fee Related
- 1996-06-03 CN CN96195860A patent/CN1192206A/zh active Pending
- 1996-06-03 PT PT96916978T patent/PT830345E/pt unknown
- 1996-06-03 EP EP96916978A patent/EP0830345B1/en not_active Expired - Lifetime
- 1996-06-03 WO PCT/US1996/008375 patent/WO1996039391A1/en not_active Application Discontinuation
- 1996-06-03 AU AU59684/96A patent/AU711965B2/en not_active Ceased
- 1996-06-03 BR BR9609153A patent/BR9609153A/pt unknown
- 1996-06-03 HU HU9900679A patent/HUP9900679A3/hu unknown
- 1996-06-03 DK DK96916978T patent/DK0830345T3/da active
- 1996-06-03 ES ES96916978T patent/ES2162063T3/es not_active Expired - Lifetime
- 1996-06-03 JP JP9500994A patent/JPH11506753A/ja active Pending
- 1996-06-03 NZ NZ309499A patent/NZ309499A/xx unknown
- 1996-06-03 AT AT96916978T patent/ATE205196T1/de not_active IP Right Cessation
- 1996-06-03 HU HU9900914A patent/HUP9900914A2/hu unknown
- 1996-06-03 CA CA002223585A patent/CA2223585A1/en not_active Abandoned
- 1996-06-05 ZA ZA9604693A patent/ZA964693B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK0830345T3 (da) | 2001-11-19 |
| ES2162063T3 (es) | 2001-12-16 |
| MX9709647A (es) | 1998-07-31 |
| HUP9900914A2 (hu) | 1999-07-28 |
| EP0830345B1 (en) | 2001-09-05 |
| CN1192206A (zh) | 1998-09-02 |
| IL118385A0 (en) | 1996-09-12 |
| US6444694B1 (en) | 2002-09-03 |
| WO1996039391A1 (en) | 1996-12-12 |
| ZA964693B (en) | 1997-12-05 |
| AR002749A1 (es) | 1998-04-29 |
| NZ309499A (en) | 2000-08-25 |
| AU711965B2 (en) | 1999-10-28 |
| HUP9900679A2 (hu) | 1999-09-28 |
| BR9609153A (pt) | 1999-05-04 |
| DE69615023D1 (de) | 2001-10-11 |
| KR19990022266A (ko) | 1999-03-25 |
| DE69615023T2 (de) | 2002-06-06 |
| EP0830345A1 (en) | 1998-03-25 |
| PT830345E (pt) | 2002-01-30 |
| JPH11506753A (ja) | 1999-06-15 |
| AU5968496A (en) | 1996-12-24 |
| CA2223585A1 (en) | 1996-12-12 |
| ATE205196T1 (de) | 2001-09-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9802300A3 (en) | N-heteroaryl-pyridinesulfonamide derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
| IL134871A (en) | Polymeric derivatives of camptothecins, process for producing such derivatives and pharmaceutical compositions containing them | |
| HUP9801599A3 (en) | Use of imidazolin derivatives having alfa1l agonist effect for producing pharmaceutical compositions for treatment of incontinence, novel imidazolin derivatives and process for producing them | |
| HUP0102677A3 (en) | Trisubstituted imidazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
| PL327275A1 (en) | Matalproteinase inhibitors, pharmaceutic compositions containing them and their application as well as method of and substrates for obtaining them | |
| SI1156049T1 (en) | Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them | |
| HUP9602511A3 (en) | Aryl-diazinone derivatives, pharmaceutical compositions containing them, and process for producing all these | |
| HUP9802694A3 (en) | Benzamide derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9600211A3 (en) | Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them, as an activ ingredient | |
| HUP9802315A3 (en) | Thrombin inhibitors, process for producing them and use of them for producing pharmaceutical compositions | |
| PL324430A1 (en) | Novel inhibitors of pharnesiltransferase, their production and pharmaceutic compositions containing them | |
| HUP9802857A3 (en) | 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors, process for producing them and pharmaceutical compositions containing them | |
| PL321710A1 (en) | Novel inhibitors of farnseferase, their production and pharmaceutic compositions containing them | |
| HUP9802323A3 (en) | Pyrimidine derivatives , process for producing them and pharmaceutical compositions containing them | |
| HUP9600071A3 (en) | Indolo-piperidine derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
| HUP9701265A3 (en) | Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them | |
| IS4635A (is) | 4-fenýlamínóþíasólafleiður, aðferð við að framleiða þær og lyfjablöndur sem innihalda þær | |
| HUP9603023A3 (en) | Substituted (sulfonimidamido)benzoyl-guanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9602681A1 (en) | Hydroxy-pyridinone derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9600876A3 (en) | Benzonitril- and -fluoride derivatives, pharmaceutical compositions containing them, process for producing them and their use | |
| HUP0002921A3 (en) | Cyanoguanidines as cell proliferation inhibitors, process for producing them and pharmaceutical compositions containing them | |
| HUP9904063A3 (en) | Pde iv inhibiting 2-(cyanoimino)imidazole derivatives, their use, process for producing them and pharmaceutical compositions containing them | |
| HUP9602635A2 (en) | 4-aciloxy-benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0002952A3 (en) | Benzimidazole derivatives, process for producing them, their use and pharmaceutical compositions containing them | |
| HU9800781D0 (en) | Propanolamine derivatives, process for producing them, pharmaceutical compositions containing them and their use |